Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,059
Closed -$1M 481
2022
Q1
$1M Buy
13,059
+2,434
+23% +$175K 0.01% 338
2021
Q4
$813K Sell
10,625
-7,003
-40% -$515K 0.01% 364
2021
Q3
$1.3M Buy
17,628
+4,691
+36% +$352K 0.01% 291
2021
Q2
$863K Buy
12,937
+9,725
+303% +$650K 0.01% 350
2021
Q1
$239K Sell
3,212
-1,339
-29% -$102K ﹤0.01% 515
2020
Q4
$331K Sell
4,551
-154
-3% -$10.9K ﹤0.01% 417
2020
Q3
$313K Sell
4,705
-14,209
-75% -$899K ﹤0.01% 360
2020
Q2
$1.08M Buy
18,914
+393
+2% +$19.3K 0.01% 233
2020
Q1
$650K Buy
+18,521
New +$882K 0.01% 248

Other funds holding HOLX

Pendal Group's HOLX Position: Q2 2022 in Review

Pendal Group sold out of Hologic (HOLX) in Q2 2022, closing a stake of 13,059 shares — an estimated $1M sold.

Pendal Group first reported a position in HOLX in Q1 2020 and held it in 9 quarters. The position peaked at $1.3M in Q3 2021. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Pendal Group reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Pendal Group sold 13,059 Hologic shares in Q2 2022, an estimated $1M.
  • Pendal Group first reported a position in Hologic in Q1 2020 and held it in 9 quarters.
  • Pendal Group's Hologic position peaked at $1.3M in Q3 2021.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Pendal Group's 13F filing for Q2 2022, filed 25 Jul 2022.